On July 6, Shandong Sanyuan Biotechnology Co., Ltd. (stock code: 301206) issued an outward investment announcement, declaring that it plans to use its own funds of CNY 30,000 thousand to inject capital into Shenzhen Youwei Optoelectronics Co., Ltd. (有维光电). Upon completion of the transaction, Sanyuan Bio will hold a 10.7143% stake in Youwei Optoelectronics, marking the company’s official entry into the optoelectronic device field.
Investment Target: Youwei Optoelectronics
Founded in July 2023, Youwei Optoelectronics has a registered capital of CNY 11,666.7 thousand and is located in Longhua District, Shenzhen. The company’s core business focuses on the R&D and production of products such as CLBO crystals, all-solid-state lasers and YIG bulk single crystals.
According to the announcement, the pricing of this capital increase refers to the valuation of Youwei Optoelectronics’ previous market-based financing round, and the pre-money valuation of the target company was agreed at CNY 250 million after negotiation. Sanyuan Bio subscribed, in full and in cash of CNY 30,000 thousand, for CNY 1,400 thousand of the newly added registered capital, of which CNY 28,600 thousand was credited to capital reserve.
Financial Data
As a start-up, Youwei Optoelectronics is still in the R&D investment stage:
- 2024: operating revenue of CNY 208.4 thousand and a net loss of CNY 4,916.6 thousand
- 2025: operating revenue of CNY 11,358.8 thousand and a net loss of CNY 7,539.5 thousand
- January-May 2026: operating revenue of CNY 636.7 thousand and a net loss of CNY 2,636.4 thousand
Purpose of the Investment
Sanyuan Bio said this outward investment is a strategic move to cultivate a medium- and long-term second growth curve for the company on the basis of the steady development of its core main business of healthy sweetening ingredients. The investment amount accounts for 0.68% and 0.71% of the company’s most recently audited total assets and net assets respectively, making it a prudent investment attempt within a controllable risk range.
Industry Observations
This is another capital injection into the optoelectronics field after companies such as Xili Optoelectronics (犀里光电) obtained financing. As a food additive company investing across sectors into optoelectronic devices, Sanyuan Bio reflects capital’s recognition of the long-term development prospects of the optoelectronics track. Youwei Optoelectronics’ technology layout in CLBO crystals and all-solid-state lasers is also worth the attention of laser industry practitioners.
Sources: Sanyuan Bio announcement, Securities Times



Leave a Reply